The economic burden of coronavirus disease 2019 (COVID-19): evidence from Iran
نویسندگان
چکیده
Abstract This study aimed to estimate both direct medical and indirect costs of treating the Coronavirus disease 2019 (COVID-19) from a societal perspective in patients at referral hospital Fars province as well economic burden COVID-19 Iran 2020. Methods is partial evaluation cross-sectional cost-description conducted based on data referred university between March July The were collected by examining patients’ records accounting information systems. subjects included all inpatients with (477 individuals) who admitted centre during 4 months. Bottom-up costing (also called micro-costing approach), incidence-based income-based human capital approaches used main methodological features this study. Results estimated be 28,240,025,968 Rials ($ 1,791,172) total mean cost 59,203,409 3755) per person (SD = 4684 $/ 73,855,161 Rials) which significant part (41%) was that intensive general care beds (11,596,217,487 equal $ 735,510 (M 24,310,728 or 1542, SD 34,184,949 2168(. second medicines consumables (28%). costs, including income loss due premature death, production hospitalization job absenteeism recovery course 129,870,974 11,634) person. Furthermore, country for inpatient cases definitive diagnosis 22,688,925,933,095 1,439,083,784. Conclusion results showed severe status would bring about extremely high illness case. It prevalence rate has been imposing heavy health system directly may result rationing painful cost-control approaches.
منابع مشابه
Obesity and Coronavirus Disease 2019 (COVID-19)
Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection that was first reported on December 31, 2019 in China . This disease behaves variously: from asymptomatic infection to influenza-like symptoms and severe acute respiratory distress syndrome (ARDS) . In the recent months, COVID-19 has infected millions and killed hundre...
متن کاملUnderstanding the 2019-novel Coronavirus (2019-nCoV) and Coronavirus Disease (COVID-19) Based on Available Evidence - A Review Study
Since December 2019, a new coronavirus, called the 2019-novel coronavirus (2019-nCoV), triggers pneumonia outbreak from Wuhan (Huanan seafood market) across China, which now poses major health threats to public health. The Corona Virus Disease-2019 (COVID-19) epidemic by 2019-nCoV is spreading worldwide, and by March 1, 2020, 67 countries, including Iran, have been affected. According to worldw...
متن کاملA Review of Coronavirus Disease-2019 (COVID-19)
There is a new public health crises threatening the world with the emergence and spread of 2019 novel coronavirus (2019-nCoV). The virus originated in bats and was transmitted to humans through yet unknown intermediary animals in Wuhan, China in December 2019. The virus spreads faster than its two ancestors the SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV), but has lower ...
متن کاملA Review of Pharmacotherapy for Coronavirus Disease 2019 (COVID-19)
The epidemic of COVID-19 and its associated acute respiratory syndrome has posed an unprecedented challenge in identifying effective drugs to prevent and treat it. Due to the high prevalence of this disease and the high number of people at risk, medical staff needs accurate evidence regarding effective drug treatments for this infection. There is currently no effective treatment for COVID-19. B...
متن کاملCoronavirus disease 2019 (COVID-19) Immunopathogenesis, Diagnosis, and Treatment
SARS-CoV-2 is a member of the coronaviruses family that causes the outbreak of coronavirus disease 2019 (COVID-19) in China in late 2019 which has exploded to a global pandemic. The reference genome of the SARS-CoV-2 is considered to be very closely related to SARS-CoV and the virus uses the ACE-2 receptor for cellular entry similar to SARS-CoV. The most common symptoms of COVID-19 are fever, c...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMC Health Services Research
سال: 2021
ISSN: ['1472-6963']
DOI: https://doi.org/10.1186/s12913-021-06126-8